Irhythm Technologies Inc. (IRTC)
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised
iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Q1 2026 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Holdings, Inc. (IRTC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.95 per share a year ago.
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the outlook.
Cinctive Capital Management LP Takes $4.82 Million Position in iRhythm Technologies $IRTC
Cinctive Capital Management LP acquired a new stake in shares of iRhythm Technologies (NASDAQ: IRTC) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 28,044 shares of the company's stock, valued at approximately $4,823,000. Cinctive Capital Management LP owned about 0.09%
iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call Transcript
iRhythm Holdings, Inc. (IRTC) Q4 Earnings and Revenues Beat Estimates
iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago.
IRHYTHM HLDGS (IRTC) Moves 5.0% Higher: Will This Strength Last?
IRHYTHM HLDGS (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating
iRhythm Technologies stock has doubled this year.
iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript
iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & Director Daniel Wilson - CFO & Principal Financial Officer Conference Call Participants Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division David Saxon - Needham & Company, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Stephanie Piazzola - BofA Securities, Research Division Max Kruszeski - William Blair & Company L.L.C.
